2014
Arsenic methylation capacity is associated with breast cancer in northern Mexico
López-Carrillo L, Hernández-Ramírez RU, Gandolfi AJ, Ornelas-Aguirre JM, Torres-Sánchez L, Cebrian ME. Arsenic methylation capacity is associated with breast cancer in northern Mexico. Toxicology And Applied Pharmacology 2014, 280: 53-59. PMID: 25062773, DOI: 10.1016/j.taap.2014.07.013.Peer-Reviewed Original ResearchConceptsPrimary methylation indexBC riskSecondary methylation indexHospital-based case-control studyMethylation indexMethylation capacityHigher BC riskBreast cancer incidenceCase-control studyRisk of BCBiological exposure indexArsenic methylation capacityMetabolite percentagesDietary factorsCancer incidenceBreast cancerIAs metabolismMost womenTotal urinaryReproductive historyBC carcinogenesisInter-individual variationWomenExposure indexRisk
2013
PPARγ and PPARGC1B polymorphisms modify the association between phthalate metabolites and breast cancer risk
Martínez-Nava GA, Burguete-García AI, López-Carrillo L, Hernández-Ramírez RU, Madrid-Marina V, Cebrián ME. PPARγ and PPARGC1B polymorphisms modify the association between phthalate metabolites and breast cancer risk. Biomarkers 2013, 18: 493-501. PMID: 23866026, DOI: 10.3109/1354750x.2013.816776.Peer-Reviewed Original Research